SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001437749-24-009735
Filing Date
2024-03-28
Accepted
2024-03-28 11:06:39
Documents
39
Period of Report
2024-03-28
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A opk20240328_8ka.htm   iXBRL 8-K/A 27876
2 EXHIBIT 2.1 ex_646825.htm EX-2.1 563825
3 EXHIBIT 99.1 ex_646807.htm EX-99.1 13397
8 page1c.jpg GRAPHIC 53821
9 page2d.jpg GRAPHIC 257003
10 page3c.jpg GRAPHIC 174821
11 page4c.jpg GRAPHIC 200362
12 page5c.jpg GRAPHIC 175595
13 page6c.jpg GRAPHIC 144918
14 page7c.jpg GRAPHIC 196235
15 page8c.jpg GRAPHIC 173728
16 page10c.jpg GRAPHIC 160763
17 page11c.jpg GRAPHIC 181613
18 page12c.jpg GRAPHIC 139998
19 page13c.jpg GRAPHIC 36535
20 page14c.jpg GRAPHIC 124809
21 page15c.jpg GRAPHIC 217425
22 page16c.jpg GRAPHIC 142777
23 page17c.jpg GRAPHIC 196011
24 page18c.jpg GRAPHIC 204611
25 page19c.jpg GRAPHIC 42460
26 page20c.jpg GRAPHIC 218378
27 page21c.jpg GRAPHIC 171610
28 page22c.jpg GRAPHIC 40959
29 page23c.jpg GRAPHIC 201684
30 page24c.jpg GRAPHIC 28844
  Complete submission text file 0001437749-24-009735.txt   5649689

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA opk-20240328.xsd EX-101.SCH 3401
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE opk-20240328_def.xml EX-101.DEF 11789
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE opk-20240328_lab.xml EX-101.LAB 15821
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE opk-20240328_pre.xml EX-101.PRE 12004
42 EXTRACTED XBRL INSTANCE DOCUMENT opk20240328_8ka_htm.xml XML 2959
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4181
OPKO HEALTH, INC. (Filer) CIK: 0000944809 (see all company filings)

IRS No.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-33528 | Film No.: 24795286
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)